West Pharmaceutical Services is a quality firm that is doing well right now. But is WST stock a buy at current levels? Click here for a full investment analysis.
West Pharmaceutical Services, I found using ticker (WST) now have 6 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 449 and 330 with the average target price sitting at 383.17. Now with the previous closing price of 253.11 this would indicate that there is a potential upside of 51.4%. The 50 day moving average now sits at 309.46 and the 200 day MA is 351.67. The market cap for the company is $18,826m. You can visit the company''s website by visiting: https://www.westpharma.com [stock_market_widget type="chart" template="basic" color="green" assets="WST" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $28,500m based on the market concensus. West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Calculating The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) Nasdaq
At the close of the New York Stock Exchange, the Dow Jones fell 0.56% to a one-month low, the S&P 500 fell 1.13% and the NASDAQ Composite fell 1.43%. UnitedHealth Group Incorporated was the top performer in the Dow Jones Index today, up 13.14 points or 2.58% to close at 522.91. JPMorgan Chase & Co rose 1.75 points or 1.51% to close at 117.87. Goldman Sachs Group Inc rose 4.36 points or 1.33% to close at 331.62. The losers were Salesforce Inc, which shed 5.50 points or 3.43% to end the session at 154.78. Microsoft Corporation was up 2.71% or 6.84 points to close at 245.38, while Visa Inc Class A was down 2.03% or 4.04 points to close at 195. .37. Leading gainers among the S&P 500 index components in today''s trading were Humana Inc, which rose 8.37% to 497.24, Wynn Resorts Limited, which gained 7.48% to close at 65.23, and shares of Paramount Global Class B, which rose 5.16% to close the session at 23.05. The losers were Adobe Systems Incorporated, which shed 16.79% to close at 309.13. Shares of Albemarle Corp shed 6.49% to end the session at 286.75.
Baron Funds, an asset management company, released its “Baron Growth Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. In the second quarter, the fund fell 18.69%. The fund performed moderately better in the quarter compared to a 19.25% decline in the Russell 2000 Growth benchmark Index. In addition, […]
West Pharmaceutical Services, I with ticker code (WST) now have 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 449 and 330 calculating the mean target price we have 383.17. With the stocks previous close at 296.1 this would imply there is a potential upside of 29.4%. There is a 50 day moving average of 316.07 and the 200 moving average now moves to 362.6. The market cap for the company is $21,574m. You can visit the company''s website by visiting: https://www.westpharma.com [stock_market_widget type="chart" template="basic" color="green" assets="WST" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,918m based on the market concensus. West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
West Pharmaceutical Services, I with ticker code (WST) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 449 and 330 calculating the mean target price we have 383.17. Given that the stocks previous close was at 314.68 this indicates there is a potential upside of 21.8%. There is a 50 day moving average of 315.27 and the 200 day MA is 365.74. The market capitalisation for the company is $22,494m. Find out more information at: https://www.westpharma.com [stock_market_widget type="chart" template="basic" color="green" assets="WST" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,389m based on the market concensus. West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
West Pharmaceutical Servs (NYSE: WST ) has outperformed the market over the past 10 years by 18.96% on an annualized basis producing an average annual return of 30.3%. Currently, West Pharmaceutical Servs has a market capitalization of $25.12 billion. Buying $1000 In WST: … Full story available on Benzinga.com
According to Benzinga Pro, during Q2, West Pharmaceutical Servs (NYSE: WST ) earned $188.50 million, a 8.46% increase from the preceding quarter. West Pharmaceutical Servs also posted a total of $771.30 million in sales, a 7.12% increase since Q1. In Q1, West Pharmaceutical Servs earned $173.80 million, and total sales reached $720.00 million. What Is Return On Capital Employed? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, … Full story available on Benzinga.com
Equities researchers at KeyCorp decreased their Q3 2022 earnings estimates for West Pharmaceutical Services in a research report issued to clients and investors on Thursday, July 28th. KeyCorp analyst … Read Full Story at source (may require registration) The post Equities Analysts Offer Predictions for West Pharmaceutical Services, Inc.’s Q3 2022 Earnings (NYSE:WST) appeared first on ForexTV .
WST earnings call for the period ending June 30, 2022.
West Pharmaceutical Services, Inc. (NYSE:NYSE:WST) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President, Investor Relations Eric Green…
The following slide deck was published by West Pharmaceutical Services, Inc.
West Pharmaceutical Servs (NYSE: WST ) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Earnings West Pharmaceutical Servs beat estimated earnings by 11.76%, reporting an EPS of $2.47 … Full story available on Benzinga.com
West Pharmaceutical (WST) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open.The consensus EPS Estimate is $2.21 (-10.2% Y/Y) and the consensus Revenue…
Related Stocks: NVDA , AMZN , WST , AMD , LLY ,
West Pharmaceutical Services (WST) has performed extraordinarily well in recent years. See why I think buying WST now won''t make sense to a lot of investors.
Hey KDGers, $WST will be listed on PancakeSwap tomorrow❗️❗️At which ROI do you think $WST can reach? Let us know below in the comment… Continue reading on Kingdom Game 4.0 »
Major players in the prefilled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc, Baxter International Inc, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, and Weigao Group. Major players in the prefilled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc, Baxter International Inc, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, and Weigao Group.
West Pharmaceutical Services (WST) CFO Bernard J. Birkett is adding the position of chief operations officer to his title.
Pune, April 06, 2022 (GLOBE NEWSWIRE) -- The global medical Medical Device Contract Manufacturing Market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product. Contract manufacturing organizations (CMOs) are selected based on the capabilities of service provided in low cost, high quality and in speculated time. With increasing need for medical devices in hospitals and meet growing demand of hospitals OEMs are collaborating with Medical device contract manufacturing organization to meet this growing need. Medical Medical Device Contract Manufacturing Market by Regions The global medical device contract manufacturing can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of medical device contract manufacturing, followed by Europe and Asia Pacific.
Pharmaceutical Vials Market report gives complete study of Market growth drivers, Current growth, market trends, Market structure, Market projections for upcoming years. This Pharmaceutical Vials Market research report is the all-inclusive understanding of the present market dynamics derived from the historical data analysis. The report clarifies the market elements, segregations, end-user industry, actions and market []
This report studies the Self-administration Injection Systems Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Self-administration Injection Systems market segmented by company, []
Related Stocks: BRK.B , AXP , CPRT , MRK , V , JKD , WST , ORI , MDYV , APH , BLV , RMBS , VAR , VHT , GWW , IWV , VFC , MHE ,
Related Stocks: XLK , CRM , MSFT , WST , FB , ETSY , IWM , TGT , MLM , ILMN , ZTS , INGN , XLE , PSCT , FSS , KEYS , MRK , LIVN ,
Related Stocks: VTIP , VGSH , XSOE , REGN , AMT , EXR , WST , DFS , ROST , SBNY ,
Top Players Covered in the Prefilled Syringes Market Research Report are BD, Gerresheimer AG, AptarGroup, Inc., Helvoet Rubber & Plastic Technologies BV, West Pharmaceutical Services Inc., SCHOTT AG, Terumo Corporation, Nipro PharmaPackaging International and other key market players Top Players Covered in the Prefilled Syringes Market Research Report are BD, Gerresheimer AG, AptarGroup, Inc., Helvoet Rubber & Plastic Technologies BV, West Pharmaceutical Services Inc., SCHOTT AG, Terumo Corporation, Nipro PharmaPackaging International and other key market players
West Pharmaceutical Services, Inc. (WST) shares closed today at 0.9% below its 52 week high of $377.19, giving the company a market cap of $27B. The stock is currently up 32.0% year-to-date, up 51.6% over the past 12 months, and up 390.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.0%. Trading Activity Trading volume this week was 21.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1718.1% The company's stock price performance over the past 12 months beats the peer average by 229.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 49.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
West Pharmaceutical Services, Inc. (WST) shares closed today at 1.4% below its 52 week high of $377.19, giving the company a market cap of $27B. The stock is currently up 31.4% year-to-date, up 54.5% over the past 12 months, and up 388.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 24.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2702.0% The company's stock price performance over the past 12 months beats the peer average by 240.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 50.4% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Stocks Analysis by Zacks Investment Research covering: Amazon.com Inc, Netflix Inc, West Pharmaceutical Services Inc, Bitcoin. Read Zacks Investment Research''s latest article on Investing.com
EXTON, Pa., July 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2021 financial results before the market opens on Thursday, July 29,
The fill finish manufacturing market was valued at US$ 6,129.03 million in 2019 and is projected to reach US$ 12,547.23 million by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027. Worldwide Fill Finish Manufacturing
Related Stocks: APD , DLR , IFF , AMGN , GIS , SJM , WST , DOV , SLB , KSU , EMR , STT ,
If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe. The post West Pharmaceutical Services Inc (WST): Price Now Near $375.62; Daily Chart Shows An Uptrend on 20 Day Basis appeared first on ETF Daily News .
West Pharmaceutical Services (NYSE:WST) Could Easily Take On More Debt Nasdaq
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO ) ( moved on positive analyst action) Ambrx Biopharma Inc. (NYSE: AMAM ) AtriCure, Inc. (NASDAQ: ATRC ) Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Edwards Lifesciences Corporation (NYSE: EW ) Novo Nordisk A/S (NYSE: NVO ) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 8) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) ADMA Biologics, Inc. (NASDAQ: ADMA ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) (announced positive Phase 2 data for non-alcoholic steatohepatitis drug) Allogene Therapeutics, Inc.
Major players in the sterile medical packaging market are Amcor Limited, DuPont De Nemours and Company, 3M Company, West Pharmaceutical Services, Inc. , Oliver Healthcare Packaging LLC, Placon Corporation, Oracle Packaging, Riverside Medical Packaging Company Ltd, Wipak Group. Major players in the sterile medical packaging market are Amcor Limited, DuPont De Nemours and Company, 3M Company, West Pharmaceutical Services, Inc. , Oliver Healthcare Packaging LLC, Placon Corporation, Oracle Packaging, Riverside Medical Packaging Company Ltd, Wipak Group.
Major players in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc. , Baxter International Inc. , Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, Weigao Group, Novartis, Catalent Inc. Major players in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc. , Baxter International Inc. , Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, Weigao Group, Novartis, Catalent Inc.
West Pharmaceutical Services Inc. stock rises Thursday, outperforms market MarketWatch
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors MarketWatch
VALLEY FORGE, Pa.--(BUSINESS WIRE)-- #fortune500--UGI Corporation (NYSE: UGI) has named Jean Felix (JF) Tematio Dontsop as Vice President, Chief Accounting Officer (CAO), and Controller, effective July 19. Tematio Dontsop, 45, most recently served as Vice President of Internal Audit for West Pharmaceuticals in Exton, PA. Previously, he held several roles of increasing responsibility over 15 years with PricewaterhouseCoopers (PwC), based in Philadelphia, PA and Paris, France, including Audit Director of large
WA Premier Mark McGowan has called an 8pm (WST) press conference on the states COVID-19 status after one case of community spread announced earlier today did not prompt a full lockdown.
The global Prefilled Syringes Market Size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor